Boehringer Ingelheim Chairman Andreas Barner On Emerging Markets Strategy: From Clinical Trials To Commercial Launches
This article was originally published in PharmAsia News
Executive Summary
Although late in the game, Boehringer Ingelheim has set its sights on growth markets like India and in everything that it has planned, an innovative approach holds the key.